Operator
Welcome to the McKesson Q4 Earnings Call. Today s conference is being recorded. At this time, I d like to turn the conference over to you, Holly Weiss. Please go ahead.
Holly Weiss
Vice President-Investor Relations
Thank you, Stephanie. Good afternoon and welcome, everyone, to McKesson s Fourth Quarter Fiscal 2021 Earnings Call. Today, I m joined by Brian Tyler, our Chief Executive Officer; and Britt Vitalone, our Chief Financial Officer. Brian will lead off, followed by Britt, and then we will move to a question-and-answer session. Today s discussion will include forward-looking statements, such as forecasts about McKesson s operations and future results. Please refer to the cautionary statements in today s press release and our slide presentation and to the Risk Factors section of our periodic SEC filings for additional information concerning risk factors that could cause our actual results to materially differ from those in our forward-looking statements. During th
Senior Vice President, Investor Relations
Good morning and welcome everyone to McKesson s Third Quarter Fiscal 2021 Earnings Call. Today, I m joined by Brian Tyler, our Chief Executive Officer; and Britt Vitalone, our Chief Financial Officer. Brian will lead off, followed by Britt, and then we will move to a question-and-answer session.
Today s discussion will include forward-looking statements, such as forecast about McKesson s operations and future results. Please refer to the cautionary statements in today s press release and our slide presentation and to the Risk Factors section of our periodic SEC filings for additional information concerning risk factors that could cause our actual results to materially differ from those in our forward-looking statements.
Provided by PR Newswire
New Report: 36% of Patients Sacrifice Medications to Afford Basic Needs
New Report: 36% of Patients Sacrifice Medications to Afford Basic Needs
The 2021 Medication Access Report emphasizes medication access barriers further impacted by the COVID-19 pandemic and technology that can make a difference
PR Newswire
COLUMBUS, Ohio, Jan. 26, 2021
COLUMBUS, Ohio, Jan. 26, 2021 /PRNewswire/ The impact from the COVID-19 pandemic caused tens of millions of Americans to lose their jobs, health insurance and, for some, access to their medications.1 New research released today by CoverMyMeds found that 65 percent of patients were financially impacted by the COVID-19 pandemic2 and 36 percent sacrificed their treatments or medications to pay for bills and basic needs.2 Others have done the inverse: 43 percent have had to forgo paying for essential items and bills to afford needed medications,2 while 41 percent have skipped or modified medicat
New Report: 36% of Patients Sacrifice Medications to Afford Basic Needs yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
9:28 am
McKesson Corporation found using ticker (MCK) have now 16 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and low target price is between 222 and 178 calculating the mean target price we have 197.5. Now with the previous closing price of 174.66 this now indicates there is a potential upside of 13.1%. There is a 50 day moving average of 171.65 and the 200 day moving average is 157.42. The company has a market cap of $27,670m. Visit the company website at: http://www.mckesson.com
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This